Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 30% ± 11% | |
fibroblast | 9 studies | 35% ± 12% | |
T cell | 8 studies | 40% ± 14% | |
B cell | 6 studies | 46% ± 8% | |
CD4-positive, alpha-beta T cell | 6 studies | 32% ± 12% | |
conventional dendritic cell | 6 studies | 47% ± 12% | |
monocyte | 6 studies | 30% ± 8% | |
connective tissue cell | 5 studies | 26% ± 9% | |
macrophage | 5 studies | 32% ± 13% | |
CD8-positive, alpha-beta T cell | 4 studies | 37% ± 11% | |
natural killer cell | 4 studies | 26% ± 5% | |
ciliated cell | 4 studies | 23% ± 4% | |
dendritic cell | 4 studies | 25% ± 5% | |
hematopoietic precursor cell | 3 studies | 43% ± 25% | |
mature NK T cell | 3 studies | 40% ± 13% | |
myofibroblast cell | 3 studies | 24% ± 5% | |
pericyte | 3 studies | 24% ± 6% | |
gamma-delta T cell | 3 studies | 28% ± 13% | |
memory B cell | 3 studies | 43% ± 16% | |
epithelial cell | 3 studies | 27% ± 7% | |
endothelial cell of lymphatic vessel | 3 studies | 43% ± 10% | |
type II pneumocyte | 3 studies | 41% ± 17% | |
basal cell | 3 studies | 23% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 280.01 | 180 / 180 | 85% | 3.55 | 367 / 430 |
thymus | 100% | 557.30 | 653 / 653 | 85% | 3.73 | 513 / 605 |
breast | 98% | 125.21 | 451 / 459 | 57% | 1.45 | 637 / 1118 |
bladder | 100% | 278.52 | 21 / 21 | 52% | 1.90 | 260 / 504 |
kidney | 99% | 104.53 | 88 / 89 | 47% | 1.21 | 427 / 901 |
lung | 99% | 163.43 | 572 / 578 | 38% | 1.48 | 439 / 1155 |
uterus | 100% | 237.69 | 170 / 170 | 33% | 1.03 | 150 / 459 |
stomach | 100% | 139.11 | 358 / 359 | 33% | 0.84 | 93 / 286 |
intestine | 100% | 140.40 | 965 / 966 | 23% | 0.52 | 122 / 527 |
esophagus | 99% | 92.41 | 1427 / 1445 | 23% | 0.94 | 43 / 183 |
pancreas | 100% | 108.00 | 328 / 328 | 17% | 0.48 | 31 / 178 |
skin | 100% | 137.90 | 1804 / 1809 | 10% | 0.21 | 49 / 472 |
adrenal gland | 90% | 52.92 | 233 / 258 | 20% | 0.37 | 45 / 230 |
prostate | 100% | 212.04 | 244 / 245 | 7% | 0.09 | 33 / 502 |
spleen | 100% | 178.72 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.86 | 1 / 1 |
brain | 64% | 41.14 | 1689 / 2642 | 34% | 0.72 | 242 / 705 |
adipose | 98% | 94.42 | 1174 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 67.69 | 1267 / 1335 | 0% | 0 | 0 / 0 |
heart | 80% | 47.39 | 688 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 60% | 134.62 | 561 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 34% | 0.61 | 10 / 29 |
liver | 22% | 8.23 | 49 / 226 | 6% | 0.14 | 24 / 406 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.12 | 4 / 45 |
muscle | 7% | 2.41 | 57 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | ZNF90 |
Protein name | Zinc finger protein 90 Zinc finger protein 90 (Zinc finger protein HTF9) |
Synonyms | |
Description | FUNCTION: May be involved in transcriptional regulation. |
Accessions | ENST00000418063.3 F8WBQ5 ENST00000469078.5 ENST00000473524.5 F8WDJ7 Q03938 |